R, G., S, G., A, B., AM, R., S, C., B, J., . . . G, F. (2023). Posterior reversible encephalopathy syndrome (PRES) and myeloma. Leukemia research reports, 21, 100407. https://doi.org/10.1016/j.lrr.2023.100407
Chicago Style (17th ed.) CitationR, Ghanem, Glaisner S, Bobin A, Ronchetti AM, Cereja S, Joly B, Salanoubat C, and Fouquet G. "Posterior Reversible Encephalopathy Syndrome (PRES) and Myeloma." Leukemia Research Reports 21 (2023): 100407. https://doi.org/10.1016/j.lrr.2023.100407.
MLA (9th ed.) CitationR, Ghanem, et al. "Posterior Reversible Encephalopathy Syndrome (PRES) and Myeloma." Leukemia Research Reports, vol. 21, 2023, p. 100407, https://doi.org/10.1016/j.lrr.2023.100407.
Warning: These citations may not always be 100% accurate.